EW logo

Edwards Lifesciences (EW) Non Current Assets

Annual Non Current Assets

$5.33 B
+$130.80 M+2.52%

31 December 2023

EW Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$6.24 B
+$660.20 M+11.82%

30 September 2024

EW Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EW Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+17.2%
3 y3 years+0.1%+17.3%
5 y5 years+52.0%+78.2%

EW Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+2.5%at high+21.8%
5 y5 yearsat high+52.0%at high+78.2%
alltimeall timeat high+678.6%at high+905.2%

Edwards Lifesciences Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$6.24 B(+11.8%)
June 2024
-
$5.58 B(+0.3%)
Mar 2024
-
$5.57 B(+4.5%)
Dec 2023
$4.04 B(+30.4%)
$5.33 B(+0.5%)
Sept 2023
-
$5.30 B(-1.0%)
June 2023
-
$5.36 B(-0.7%)
Mar 2023
-
$5.39 B(+3.8%)
Dec 2022
$3.10 B(-2.7%)
$5.20 B(+1.4%)
Sept 2022
-
$5.12 B(-0.7%)
June 2022
-
$5.16 B(-0.3%)
Mar 2022
-
$5.18 B(-2.7%)
Dec 2021
$3.18 B(+2.9%)
$5.32 B(+14.6%)
Sept 2021
-
$4.64 B(+7.0%)
June 2021
-
$4.34 B(+4.7%)
Mar 2021
-
$4.14 B(-0.0%)
Dec 2020
$3.09 B(+3.6%)
$4.15 B(+8.5%)
Sept 2020
-
$3.82 B(+2.3%)
June 2020
-
$3.73 B(+4.6%)
Mar 2020
-
$3.57 B(+1.8%)
Dec 2019
$2.98 B(+30.5%)
$3.50 B(+8.6%)
Sept 2019
-
$3.23 B(+0.2%)
June 2019
-
$3.22 B(+3.8%)
Mar 2019
-
$3.10 B(+2.1%)
Dec 2018
$2.29 B(-10.3%)
$3.04 B(-0.3%)
Sept 2018
-
$3.05 B(+1.9%)
June 2018
-
$2.99 B(-3.8%)
Mar 2018
-
$3.11 B(-0.3%)
Dec 2017
$2.55 B(+13.8%)
$3.12 B(+6.7%)
Sept 2017
-
$2.92 B(+2.3%)
June 2017
-
$2.86 B(+3.4%)
Mar 2017
-
$2.76 B(+21.7%)
Dec 2016
$2.24 B(+9.4%)
$2.27 B(+4.7%)
Sept 2016
-
$2.17 B(+4.9%)
June 2016
-
$2.07 B(+1.6%)
Mar 2016
-
$2.03 B(+1.3%)
Dec 2015
$2.05 B(-8.2%)
$2.01 B(+16.0%)
Sept 2015
-
$1.73 B(+32.0%)
June 2015
-
$1.31 B(+6.3%)
Mar 2015
-
$1.23 B(-4.5%)
Dec 2014
$2.23 B(+29.3%)
$1.29 B(+24.1%)
Sept 2014
-
$1.04 B(-0.7%)
June 2014
-
$1.05 B(+0.0%)
Mar 2014
-
$1.05 B(+6.5%)
Dec 2013
$1.73 B(+33.6%)
$984.10 M(+2.5%)
Sept 2013
-
$960.20 M(+1.2%)
June 2013
-
$949.10 M(+1.4%)
Mar 2013
-
$935.90 M(+0.7%)
Dec 2012
$1.29 B
$929.60 M(+15.0%)
Sept 2012
-
$808.10 M(+1.5%)
June 2012
-
$796.30 M(-2.4%)
DateAnnualQuarterly
Mar 2012
-
$816.20 M(+0.5%)
Dec 2011
$1.17 B(+13.2%)
$812.00 M(+1.4%)
Sept 2011
-
$801.00 M(+2.0%)
June 2011
-
$785.60 M(+0.6%)
Mar 2011
-
$780.80 M(+6.3%)
Dec 2010
$1.03 B(+16.1%)
$734.60 M(+0.2%)
Sept 2010
-
$733.00 M(+1.4%)
June 2010
-
$723.00 M(-1.2%)
Mar 2010
-
$731.70 M(+0.7%)
Dec 2009
$889.20 M(+28.5%)
$726.30 M(+0.2%)
Sept 2009
-
$724.90 M(+0.8%)
June 2009
-
$719.50 M(+1.4%)
Mar 2009
-
$709.90 M(+0.2%)
Dec 2008
$691.90 M(+18.9%)
$708.30 M(+0.5%)
Sept 2008
-
$704.90 M(-1.2%)
June 2008
-
$713.20 M(-0.8%)
Mar 2008
-
$718.70 M(-5.9%)
Dec 2007
$581.70 M(+9.4%)
$763.40 M(+3.9%)
Sept 2007
-
$734.90 M(+3.4%)
June 2007
-
$710.60 M(+0.5%)
Mar 2007
-
$707.10 M(-1.1%)
Dec 2006
$531.60 M(+3.4%)
$715.20 M(-0.0%)
Sept 2006
-
$715.40 M(-0.2%)
June 2006
-
$716.90 M(+0.4%)
Mar 2006
-
$714.00 M(-0.1%)
Dec 2005
$514.20 M(+39.9%)
$714.90 M(+0.0%)
Sept 2005
-
$714.60 M(+0.1%)
June 2005
-
$713.70 M(-1.2%)
Mar 2005
-
$722.50 M(-3.0%)
Dec 2004
$367.50 M(+2.0%)
$745.20 M(-0.1%)
Sept 2004
-
$745.70 M(-1.4%)
June 2004
-
$756.30 M(-2.7%)
Mar 2004
-
$777.10 M(+4.8%)
Dec 2003
$360.20 M(+12.5%)
$741.20 M(+5.5%)
Sept 2003
-
$702.50 M(+1.6%)
June 2003
-
$691.50 M(+1.0%)
Mar 2003
-
$684.80 M(+0.1%)
Dec 2002
$320.20 M(+9.7%)
$684.20 M(+10.2%)
Sept 2002
-
$621.10 M(-7.5%)
June 2002
-
$671.60 M(-1.0%)
Mar 2002
-
$678.40 M(-1.8%)
Dec 2001
$292.00 M(-3.0%)
$690.90 M(+0.9%)
Sept 2001
-
$684.70 M(-0.9%)
June 2001
-
$691.00 M(-13.2%)
Mar 2001
-
$796.50 M(-1.2%)
Dec 2000
$301.00 M(-15.4%)
$806.00 M(-2.7%)
Sept 2000
-
$828.60 M(+0.1%)
June 2000
-
$828.00 M(-22.1%)
Mar 2000
-
$1.06 B
Dec 1999
$356.00 M
-

FAQ

  • What is Edwards Lifesciences annual long term assets?
  • What is the all time high annual non current assets for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly long term assets?
  • What is the all time high quarterly non current assets for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly non current assets year-on-year change?

What is Edwards Lifesciences annual long term assets?

The current annual non current assets of EW is $5.33 B

What is the all time high annual non current assets for Edwards Lifesciences?

Edwards Lifesciences all-time high annual long term assets is $5.33 B

What is Edwards Lifesciences quarterly long term assets?

The current quarterly non current assets of EW is $6.24 B

What is the all time high quarterly non current assets for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly long term assets is $6.24 B

What is Edwards Lifesciences quarterly non current assets year-on-year change?

Over the past year, EW quarterly long term assets has changed by +$916.00 M (+17.19%)